AVID BIOSCIENCES
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for the treatment and diagnosis of cancer. The Company has two platforms and are pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab, its PS-targeting agent, 124I-PGN650 (PGN650), and its brain cancer therapy Cotara. Bavituximab is the Company’s therapeutic PS-targeting antibody. PGN650 is its PS-targeting imaging agent. The Com... pany has conducted three randomized Phase II trials for bavituximab in combination with standard chemotherapy in both front and second-line NSCLC as well as front-line pancreatic cancer. In addition, it has four ongoing ISTs evaluating bavituximab with additional drug combinations in additional oncology indications
AVID BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
1981-01-01
Address:
Tustin, California, United States
Country:
United States
Website Url:
http://www.avidbio.com
Total Employee:
251+
Status:
Active
Contact:
7148389433
Email Addresses:
[email protected]
Total Funding:
285 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon Virginia Region Vimeo Akamai Hosted Level 3 Communications
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Newest Events participated
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Participated in BioProcess International West 2017
on 2017-02-27 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.avidbio.com Semrush global rank: 938.43 K Semrush visits lastest month: 29.72 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avid Biosciences"
Our Company - A world-class CDMO | Avid Bioservices, …
1993 Began biologics development and manufacturing as Peregrine Pharmaceuticals; 2002 Formed Avid Bioservices, Inc. as a wholly owned subsidiary of Peregrine Pharmaceuticals ; 2003 Signed first client for …See details»
CAPACITY TO ACCELERATE SUCCESS - Avid Bioservices, Inc.
Avid Bioservices - LinkedIn
Avid Bioservices (NASDAQ:CDMO), is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The …See details»
Avid Bioservices Unveils Completed Mammalian Cell Facilities …
Apr 4, 2023 Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on …See details»
Avid Bioservices Announces Further Expansion of Process …
Jun 13, 2022 Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The …See details»
Avid Bioservices Announces Launch of Analytical and Process …
TUSTIN, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Avid Bioservices Completes Construction of New, World-Class Cell …
TUSTIN, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Avid Bioservices Completes Construction of New, World-Class
Oct 17, 2023 Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on …See details»
Avid Bioservices Announces Expansion into Viral Vector …
TUSTIN, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Committed to Your Success. - avidbio.com
Avidbio.com a contract development and manufacturing organization which offers flexibility by uncoupling process development and manufacturing services. For this reason, with the …See details»
Avid Bioservices Completes Construction of New, World-Class Cell …
Oct 17, 2023 Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on …See details»
Avid Bioservices to be Acquired by GHO Capital Partners and …
Nov 7, 2024 Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve …See details»
News Release Details - ir.avidbio.com
Nov 6, 2024 TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics …See details»
Avid Bioservices - Overview, News & Similar companies - ZoomInfo
Jul 8, 2024 Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 TUSTIN, Calif., July 01, 2024 (GLOBE …See details»
We pride ourselves on the personal commitment our teams offer, …
Avidbio.com Cell Line & Process . Development. Pilot Scale. Production. Early & Late Phase . Clinical Supply Process Characterization & Validation. Commercial . Supply. Development, …See details»
News Release Details - ir.avidbio.com
TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Avid Bioservices to Report Financial Results for Second Quarter of ...
Nov 30, 2023 Avid Bioservices, Inc. TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and …See details»
Avid Bioservices Reports Financial Results for Third Quarter Ended ...
Jan 31, 2022 TUSTIN, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing …See details»
Avid Bioservices Appoints Oksana Lukash as Vice President, People
TUSTIN, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»